CLINICAL_TRIALS
ClinicalTrials.gov record update
Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector (MARS-NIS)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05129241
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:42.983769+00:00
- Published At
- 2025-03-24T00:00:00+00:00
- Record Updated At
- 2025-03-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Primary Hypercholesterolaemia and Mixed Dyslipidaemia", "Atherosclerotic Cardiovascular Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-24"- protocolSection.identificationModule.nctId
"NCT05129241"- protocolSection.identificationModule.officialTitle
"Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT\u00ae) With the 2 ml SYDNEY Auto-injector (MARS-NIS)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.